Literature DB >> 21164266

Glucocorticoid resistance.

E F C van Rossum, E L T van den Akker.   

Abstract

Changes in glucocorticoid (GC) receptor sensitivity can be categorized in three different types. First, generalized GC resistance syndrome is a hereditary disease. Patients present with signs and symptoms of increased androgen and/or mineralocorticoid action, combined with biochemical hypercortisolism, but lack of cushingoid features. Second, at a tissue level, transient changes in GC sensitivity are present during disease. Transient changes in GC sensitivity of leukocytes during infectious diseases like sepsis have been found, but also acquired forms or GC resistance occur, in particular in some types of neoplasms, major depression, AIDS, and several autoimmune diseases. Third, at the level of the general population, the diversity in GC sensitivity has a wide interindividual variation which in part can be explained by genetic variation of the GC receptor gene. Several single nucleotide polymorphisms of the gene have been associated with changes in GC sensitivity and its clinical phenotype. In this chapter, four genetic variants are described of which two (rs6198 and rs6189/6190) are associated with a relative GC resistance and two (rs1695 and rs41423247) are associated with a relative GC hypersensitivity.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164266     DOI: 10.1159/000321234

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  18 in total

1.  Dosing of glucocorticosteroids in nephrotic syndrome.

Authors:  Otto Mehls; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2011-09-09       Impact factor: 3.714

2.  Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.

Authors:  X Wang; P Chen; Y Sun; Y Chen; M Mao; T Jiang; J Ouyang
Journal:  Clin Transl Oncol       Date:  2017-04-25       Impact factor: 3.405

3.  The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use.

Authors:  David M Haas; Amalia S Lehmann; Todd Skaar; Santosh Philips; Catherine L McCormick; Kyle Beagle; Scott J Hebbring; Jessica Dantzer; Lang Li; Jeesun Jung
Journal:  Am J Obstet Gynecol       Date:  2012-02-28       Impact factor: 8.661

Review 4.  Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction.

Authors:  Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

5.  Impact of environmental factors on efficacy of glucocorticoids in Chinese population with systemic lupus erythematosus.

Authors:  Yan-Feng Zou; Jian-Hua Xu; Jin-Hui Tao; Sheng-Qian Xu; Shuang Liu; Shan-Yu Chen; Jing Cai; Li Lian; Pei-Ling Chen; De-Guang Wang; Sheng-Xiu Liu; Chun-Mei Liang; Qian-Ling Ye; Guo Tian; Min Wu; Hai-Feng Pan; Fa-Ming Pan; Hong Su; Dong-Qing Ye
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 6.  Pharmacogenetics and individualizing drug treatment during pregnancy.

Authors:  David M Haas
Journal:  Pharmacogenomics       Date:  2014-01       Impact factor: 2.533

7.  Association of HSP90B1 genetic polymorphisms with efficacy of glucocorticoids and improvement of HRQoL in systemic lupus erythematosus patients from Anhui Province.

Authors:  Xiu-Xiu Sun; Su-Su Li; Man Zhang; Qiao-Mei Xie; Jian-Hua Xu; Sheng-Xiu Liu; Yuan-Yuan Gu; Fa-Ming Pan; Jin-Hui Tao; Sheng-Qian Xu; Shuang Liu; Jing Cai; De-Guang Wang; Long Qian; Chun-Huai Wang; Li Lian; Hui Xiao; Pei-Ling Chen; Chun-Mei Liang; You-Bing Fang; Qiang Zhou; Hai-Liang Huang; Hong Su; Hai-Feng Pan; Dong-Qing Ye; Yan-Feng Zou
Journal:  Am J Clin Exp Immunol       Date:  2018-04-05

8.  Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.

Authors:  Ekaterina Lesovaya; Alexander Yemelyanov; Kirill Kirsanov; Alexander Popa; Gennady Belitsky; Marianna Yakubovskaya; Leo I Gordon; Steven T Rosen; Irina Budunova
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

9.  Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus.

Authors:  Yan-Feng Zou; Jian-Hua Xu; Fa-Ming Pan; Jin-Hui Tao; Sheng-Qian Xu; Hui Xiao; Shuang Liu; Jing Cai; Li Lian; Pei-Ling Chen; De-Guang Wang; Sheng-Xiu Liu; Chun-Mei Liang; Qian-Ling Ye; Guo Tian; Min Wu; Yuan-Yuan Gu; Hai-Feng Pan; Hong Su; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2015-08-09       Impact factor: 2.980

10.  Bifunctional ligands allow deliberate extrinsic reprogramming of the glucocorticoid receptor.

Authors:  Jonas W Højfeldt; Osvaldo Cruz-Rodríguez; Yasuhiro Imaeda; Aaron R Van Dyke; James P Carolan; Anna K Mapp; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2014-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.